(Q43268376)

17 November 2017

title

Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects (English)

1 reference

17 November 2017

1 reference

2

1 reference

17 November 2017

4

1 reference

17 November 2017

Patrício Soares-da-Silva

9

1 reference

17 November 2017

Teresa Nunes

1

1 reference

17 November 2017

José-Francisco Rocha

3

1 reference

17 November 2017

Carlos Fernandes-Lopes

5

1 reference

17 November 2017

Ana I Loureiro

6

1 reference

17 November 2017

Lyndon Wright

7

1 reference

17 November 2017

M Vaz-da-Silva

8

1 reference

17 November 2017

publication date

1 October 2009

1 reference

The Journal of Clinical Pharmacology

17 November 2017

published in

1 reference

17 November 2017

volume

49

1 reference

17 November 2017

issue

12

1 reference

17 November 2017

page(s)

1477-1482

1 reference

Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270009339191

Biological effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009339191

Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009339191

Potential mechanism by which resveratrol, a red wine constituent, protects neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009339191

Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009339191

Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009339191

Resveratrol--a boon for treating Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009339191

On sample size calculation in bioequivalence trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009339191

High absorption but very low bioavailability of oral resveratrol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009339191

Metabolism and bioavailability of trans-resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009339191

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009339191

Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009339191

Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009339191

21 January 2018

Identifiers

DOI

10.1177/0091270009339191

1 reference

17 November 2017

1 reference